Zyversa Therapeutics Stock Price History

ZVSA Stock   1.36  0.03  2.16%   
If you're considering investing in ZyVersa Stock, it is important to understand the factors that can impact its price. As of today, the current price of ZyVersa Therapeutics stands at 1.36, as last reported on the 3rd of February, with the highest price reaching 1.37 and the lowest price hitting 1.30 during the day. ZyVersa Therapeutics shows Sharpe Ratio of -0.0823, which attests that the company had a -0.0823 % return per unit of risk over the last 3 months. ZyVersa Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ZyVersa Therapeutics' Mean Deviation of 5.44, standard deviation of 9.26, and Market Risk Adjusted Performance of (0.05) to validate the risk estimate we provide.
  
At present, ZyVersa Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 39.2 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 59.6 K. . At present, ZyVersa Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.07, whereas Price Earnings Ratio is forecasted to decline to (0.01). ZyVersa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0823

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsZVSA

Estimated Market Risk

 8.17
  actual daily
72
72% of assets are less volatile

Expected Return

 -0.67
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average ZyVersa Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ZyVersa Therapeutics by adding ZyVersa Therapeutics to a well-diversified portfolio.
Price Book
0.4961
Book Value
27.331
Enterprise Value
357.4 K
Enterprise Value Ebitda
(2.21)
Shares Float
M

ZyVersa Therapeutics Stock Price History Chart

There are several ways to analyze ZyVersa Stock price data. The simplest method is using a basic ZyVersa candlestick price chart, which shows ZyVersa Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 5, 20242.54
Lowest PriceDecember 3, 20241.0

ZyVersa Therapeutics February 3, 2025 Stock Price Synopsis

Various analyses of ZyVersa Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ZyVersa Stock. It can be used to describe the percentage change in the price of ZyVersa Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ZyVersa Stock.
ZyVersa Therapeutics Price Daily Balance Of Power(0.43)
ZyVersa Therapeutics Price Action Indicator 0.01 
ZyVersa Therapeutics Accumulation Distribution 3,440 
ZyVersa Therapeutics Price Rate Of Daily Change 0.98 

ZyVersa Therapeutics February 3, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in ZyVersa Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ZyVersa Therapeutics intraday prices and daily technical indicators to check the level of noise trading in ZyVersa Stock and then apply it to test your longer-term investment strategies against ZyVersa.

ZyVersa Stock Price History Data

The price series of ZyVersa Therapeutics for the period between Tue, Nov 5, 2024 and Mon, Feb 3, 2025 has a statistical range of 1.54 with a coefficient of variation of 24.42. The daily prices for the period are distributed with arithmetic mean of 1.32. The median price for the last 90 days is 1.24. The company experienced 1:10 stock split on 26th of April 2024.
OpenHighLowCloseVolume
02/03/2025 1.32  1.37  1.30  1.36  67,316 
01/31/2025 1.39  1.39  1.34  1.39  32,342 
01/30/2025 1.35  1.39  1.34  1.38  17,118 
01/29/2025 1.34  1.42  1.34  1.37  17,163 
01/28/2025 1.40  1.43  1.35  1.36  40,445 
01/27/2025 1.44  1.44  1.37  1.41  73,485 
01/24/2025 1.52  1.52  1.43  1.48  58,658 
01/23/2025 1.39  1.54  1.33  1.51  212,273 
01/22/2025 1.49  1.49  1.35  1.40  121,615 
01/21/2025 1.42  1.54  1.42  1.48  205,964 
01/17/2025 1.34  1.43  1.33  1.42  128,516 
01/16/2025 1.36  1.47  1.31  1.35  133,267 
01/15/2025 1.49  1.54  1.32  1.41  285,552 
01/14/2025 1.31  1.60  1.31  1.49  723,224 
01/13/2025 1.43  1.63  1.25  1.33  1,260,223 
01/10/2025 1.65  1.95  1.35  1.47  38,271,178 
01/08/2025 1.18  1.21  1.18  1.18  75,461 
01/07/2025 1.24  1.27  1.20  1.23  43,030 
01/06/2025 1.25  1.28  1.19  1.25  77,567 
01/03/2025 1.10  1.27  1.09  1.24  162,386 
01/02/2025 1.06  1.12  1.05  1.09  58,775 
12/31/2024 1.05  1.10  1.04  1.06  52,811 
12/30/2024 1.11  1.13  1.06  1.07  147,131 
12/27/2024 1.25  1.29  1.00  1.15  169,147 
12/26/2024 1.12  1.23  1.10  1.23  60,248 
12/24/2024 1.17  1.17  1.10  1.15  32,113 
12/23/2024 1.19  1.23  1.12  1.17  78,281 
12/20/2024 1.19  1.32  1.08  1.14  244,768 
12/19/2024 1.12  1.42  1.10  1.24  1,225,514 
12/18/2024 1.03  1.16  1.01  1.10  248,966 
12/17/2024 1.01  1.05  0.99  1.00  90,478 
12/16/2024 1.07  1.08  1.02  1.03  47,325 
12/13/2024 1.08  1.11  1.03  1.05  102,073 
12/12/2024 1.13  1.13  1.06  1.08  46,500 
12/11/2024 1.11  1.20  1.10  1.12  93,001 
12/10/2024 1.07  1.14  1.03  1.14  107,232 
12/09/2024 1.04  1.15  1.00  1.06  157,542 
12/06/2024 1.03  1.03  0.99  1.02  35,042 
12/05/2024 1.03  1.04  0.99  1.03  39,234 
12/04/2024 1.02  1.02  1.00  1.02  26,491 
12/03/2024 1.03  1.05  0.98  1.00  110,853 
12/02/2024 1.08  1.09  1.01  1.03  144,544 
11/29/2024 1.06  1.09  1.04  1.07  86,545 
11/27/2024 1.07  1.09  1.03  1.07  118,400 
11/26/2024 1.12  1.13  1.05  1.07  236,705 
11/25/2024 1.13  1.14  1.10  1.11  67,495 
11/22/2024 1.13  1.13  1.06  1.13  136,364 
11/21/2024 1.15  1.18  1.12  1.14  243,239 
11/20/2024 1.13  1.19  1.10  1.15  2,678,022 
11/19/2024 1.24  1.28  1.21  1.23  133,198 
11/18/2024 1.18  1.27  1.10  1.24  267,281 
11/15/2024 1.12  1.14  1.05  1.08  115,092 
11/14/2024 1.22  1.22  1.10  1.13  252,891 
11/13/2024 1.26  1.27  1.17  1.25  115,597 
11/12/2024 1.25  1.33  1.20  1.26  261,558 
11/11/2024 1.42  1.43  1.23  1.30  284,448 
11/08/2024 1.58  1.67  1.27  1.40  321,234 
11/07/2024 1.45  1.88  1.45  1.52  838,562 
11/06/2024 1.86  1.86  1.34  1.54  2,092,055 
11/05/2024 2.66  3.37  2.35  2.54  63,261,256 
11/04/2024 1.90  1.90  1.82  1.82  50,494 

About ZyVersa Therapeutics Stock history

ZyVersa Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ZyVersa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ZyVersa Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ZyVersa Therapeutics stock prices may prove useful in developing a viable investing in ZyVersa Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding112.1 K59.6 K
Net Loss-12.7 M-13.3 M

ZyVersa Therapeutics Stock Technical Analysis

ZyVersa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ZyVersa Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ZyVersa Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

ZyVersa Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ZyVersa Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ZyVersa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ZyVersa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for ZyVersa Stock analysis

When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data